Correlation Between TechPrecision Common and Monopar Therapeutics

Can any of the company-specific risk be diversified away by investing in both TechPrecision Common and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TechPrecision Common and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TechPrecision Common and Monopar Therapeutics, you can compare the effects of market volatilities on TechPrecision Common and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TechPrecision Common with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of TechPrecision Common and Monopar Therapeutics.

Diversification Opportunities for TechPrecision Common and Monopar Therapeutics

-0.12

Correlation Coefficient

TechPrecision Common  Monopar Therapeutics

Good diversification

The 3 months correlation between TechPrecision and Monopar is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding TechPrecision Common and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and TechPrecision Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TechPrecision Common are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of TechPrecision Common i.e., TechPrecision Common and Monopar Therapeutics go up and down completely randomly.

Pair Corralation between TechPrecision Common and Monopar Therapeutics

Given the investment horizon of 90 days TechPrecision Common is expected to generate 0.88 times more return on investment than Monopar Therapeutics. However, TechPrecision Common is 1.14 times less risky than Monopar Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  295.00  in TechPrecision Common on May 5, 2025 and sell it today you would earn a total of  186.00  from holding TechPrecision Common or generate 63.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

TechPrecision Common  vs.  Monopar Therapeutics

TechPrecision Common

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in TechPrecision Common are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental indicators, TechPrecision Common unveiled solid returns over the last few months and may actually be approaching a breakup point.

Monopar Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Monopar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Monopar Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with TechPrecision Common and Monopar Therapeutics

The main advantage of trading using opposite TechPrecision Common and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TechPrecision Common position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.

The idea behind TechPrecision Common and Monopar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.